Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

February 15, 2022; Volume 19,Issue 2

Editorial

  • You have access
    Highlighted multi-modifications of enzymes: a novel succinylation mediated by histone acetyltransferase 1 in tumors
    Xiaodong Zhang, Chunyu Hou and Guang Yang
    Cancer Biology & Medicine February 2022, 19 (2) 133-135; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0533
  • You have access
    A CRISPR-Cas9 screen shows the combination efficacy of lenvatinib plus epidermal growth factor receptor inhibitors for treatment of liver cancer
    Yuchen Guo, Yangyang Zhou and Wenxin Qin
    Cancer Biology & Medicine February 2022, 19 (2) 136-139; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0520
  • You have access
    The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
    Qian Hao and Xiang Zhou
    Cancer Biology & Medicine February 2022, 19 (2) 140-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0577

Review

  • You have access
    Tumorigenic bacteria in colorectal cancer: mechanisms and treatments
    Sha Li, Jinyi Liu, Xiangjin Zheng, Liwen Ren, Yihui Yang, Wan Li, Weiqi Fu, Jinhua Wang and Guanhua Du
    Cancer Biology & Medicine February 2022, 19 (2) 147-162; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0651
  • You have access
    Cancer metabolism and dietary interventions
    Lin Qian, Fan Zhang, Miao Yin and Qunying Lei
    Cancer Biology & Medicine February 2022, 19 (2) 163-174; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0461
  • You have access
    Global pattern and trends of colorectal cancer survival: a systematic review of population-based registration data
    Yufei Jiang, Huiyun Yuan, Zhuoying Li, Xiaowei Ji, Qiuming Shen, Jiayi Tuo, Jinghao Bi, Honglan Li and Yongbing Xiang
    Cancer Biology & Medicine February 2022, 19 (2) 175-186; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0634
  • You have access
    The advance of adjuvant treatment for triple-negative breast cancer
    Jingyu Ge, Wenjia Zuo, Yiyu Chen, Zhiming Shao and Keda Yu
    Cancer Biology & Medicine February 2022, 19 (2) 187-201; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0752
  • You have access
    Updates in endocrine therapy for metastatic breast cancer
    Poorni M. Manohar and Nancy E. Davidson
    Cancer Biology & Medicine February 2022, 19 (2) 202-212; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0255

Original Article

  • You have access
    Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
    Xinyi Zhou, Qian Xiao, Dongliang Fu, Haochen Zhang, Yang Tang, Jinjie He, Yeting Hu, Xiangxing Kong, Fei Teng, Xiangrui Liu, Ying Yuan and Kefeng Ding
    Cancer Biology & Medicine February 2022, 19 (2) 213-228; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0532
  • You have access
    Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells
    Yu Yu, Minzhen Tao, Libin Xu, Lei Cao, Baoyu Le, Na An, Jilin Dong, Yajie Xu, Baoxing Yang, Wei Li, Bing Liu, Qiong Wu, Yinying Lu, Zhen Xie and Xiaohua Lian
    Cancer Biology & Medicine February 2022, 19 (2) 229-252; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0560
  • You have access
    Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women
    Fenfen Fu, Dongjie Zhang, Li Hu, Senthil Sundaram, Dingge Ying, Ying Zhang, Shuna Fu, Juan Zhang, Lu Yao, Ye Xu and Yuntao Xie
    Cancer Biology & Medicine February 2022, 19 (2) 253-262; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0358

Erratum

  • You have access
    Erratum to A truncated protein product of the germline variant of the DUOX2 gene leads to adenomatous polyposis
    Mengyuan Yang, Yingxin Zhao, Yuwei Ding, Juan Wang, Yinuo Tan, Dong Xu and Ying Yuan
    Cancer Biology & Medicine February 2022, 19 (2) 263; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.1213
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (2)
Cancer Biology & Medicine
Vol. 19, Issue 2
15 Feb 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Original Article
  • Erratum

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire